Abstract

BackgroundToday we are often interested in the predictive value of a continuous marker with respect to the expected difference in outcome between a new treatment and a standard treatment. We can investigate this in a randomized control trial, allowing us to assess interactions between treatment and marker and to construct a treatment selection rule. A first step is often to estimate the treatment effect as a function of the marker value. A variety of approaches have been suggested for the second step to define explicitly the rule to select the treatment, varying in the way to take uncertainty into account. Little is known about the merits of the different approaches.MethodsFour construction principles for the second step are compared. They are based on the root of the estimated function, on confidence intervals for the root, or on pointwise or simultaneous confidence bands. All of them have been used implicitly or explicitly in the literature. As performance characteristics we consider the probability to select at least some patients, the probability to classify patients with and without a benefit correctly, and the gain in expected outcome at the population level. These characteristics are investigated in a simulation study.ResultsAs to be expected confidence interval/band based approaches reduce the risk to select patients who do not benefit from the new treatment, but they tend to overlook patients who can benefit. Simply using positivity of the estimated treatment effect function for selection implies often a larger gain in expected outcome.ConclusionsThe use of 95% confidence intervals/bands in constructing treatment selection rules is a rather conservative approach. There is a need for better construction principles for treatment selection rules aiming to maximize the gain in expected outcome at the population level. Choosing a confidence level of 80% may be a first step in this direction.

Highlights

  • Today we are often interested in the predictive value of a continuous marker with respect to the expected difference in outcome between a new treatment and a standard treatment

  • Today we are often confronted with the task to investigate the predictive value of a continuous marker with respect to the expected difference in outcome between a new treatment and a standard treatment

  • To describe the performance of a construction method for treatment selection rules, we study the distribution of these three quality measures when applied to C under the assumption that X∗ follows the same distribution as X

Read more

Summary

Introduction

Today we are often interested in the predictive value of a continuous marker with respect to the expected difference in outcome between a new treatment and a standard treatment. We can investigate this in a randomized control trial, allowing us to assess interactions between treatment and marker and to construct a treatment selection rule. Today we are often confronted with the task to investigate the predictive value of a continuous marker with respect to the expected difference in outcome between a new treatment and a standard treatment. Estimating θ(x) is a valuable step, it does not automatically provide a rule to determine those biomarker values with θ(x) > 0; it remains the question whether and how to take stochastic uncertainty of θ(x) into account

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call